Active Ingredient History
Samidorphan is an opioid antagonist that in the form of olanzapine/samidorphan is used in the treatment of schizophrenia and bipolar disorder. Samidorphan reduces the weight gain associated with olanzapine. Samidorphan is taken by mouth. Wikipedia
Combination drugs
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Bipolar Disorder (approved 2021)
Schizophrenia (approved 2021)
Alcoholism (Phase 2)
Binge-Eating Disorder (Phase 2)
Bipolar Disorder (Phase 3)
Cocaine-Related Disorders (Phase 1)
Depression (Phase 3)
Depressive Disorder, Major (Phase 3)
Healthy Volunteers (Phase 1)
Kidney Failure, Chronic (Phase 1)
Liver Diseases (Phase 1)
Pharmacokinetics (Phase 1)
Psychotic Disorders (Phase 3)
Schizophrenia (Phase 3)
Substance-Related Disorders (Phase 1)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue